Cornercap Investment Counsel’s Encompass Health EHC Stock Holding History

Cornercap Investment Counsel’s Portfolio EHC Stock Details EHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-3,295	Closed	-$304K	–	249
2024 Q4	$304K	Hold	3,295	–	–	0.1%	354
2024 Q3	$318K	Sell	3,295 -5,501	-63%	-$494K	0.09%	351
2024 Q2	$755K	Sell	8,796 -224	-2%	-$18.8K	0.12%	302
2024 Q1	$745K	Sell	9,020 -11,010	-55%	-$806K	0.11%	322
2023 Q4	$1.34M	Buy	20,030 +1,366	+7%	+$88.5K	0.22%	123
2023 Q3	$1.25M	Sell	18,664 -283	-1%	-$19.5K	0.23%	116
2023 Q2	$1.28M	Sell	18,947 -25	-0.1%	-$1.57K	0.22%	119
2023 Q1	$1.03M	Buy	+18,972	New	+$1.1M	0.18%	200
2022 Q1	–	Sell	-19,357	Closed	-$1M	–	575
2021 Q4	$1M	Buy	19,357 +469	+2%	+$24.2K	0.15%	304
2021 Q3	$1.13M	Buy	+18,888	New	+$1.19M	0.13%	270

Other funds holding EHC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Cornercap Investment Counsel's EHC Position: Q1 2025 in Review

Cornercap Investment Counsel sold out of Encompass Health (EHC) in Q1 2025, closing a stake of 3,295 shares — an estimated $304K sold.

Cornercap Investment Counsel first reported a position in EHC in Q3 2021 and held it in 10 quarters. The position peaked at $1.34M in Q4 2023. 537 funds tracked by Wall St. Rank hold EHC as of Q1 2025.

Cornercap Investment Counsel reported no remaining Encompass Health position as of Q1 2025 after selling out during the quarter.
Cornercap Investment Counsel sold 3,295 Encompass Health shares in Q1 2025, an estimated $304K.
Cornercap Investment Counsel first reported a position in Encompass Health in Q3 2021 and held it in 10 quarters.
Cornercap Investment Counsel's Encompass Health position peaked at $1.34M in Q4 2023.
537 funds tracked by Wall St. Rank held Encompass Health as of Q1 2025.

Based on Cornercap Investment Counsel's 13F filing for Q1 2025, filed 2 May 2025.